Northern Trust’s scPharmaceuticals SCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.08M | Sell |
283,138
-34,402
|
|
||||
|
2025
Q1 | $835K | Sell |
317,540
-6,686
|
|
||||
|
2024
Q4 | $1.15M | Buy |
324,226
+69,092
|
|
||||
|
2024
Q3 | $1.16M | Buy |
255,134
+7,212
|
|
||||
|
2024
Q2 | $1.08M | Sell |
247,922
-16,887
|
|
||||
|
2024
Q1 | $1.33M | Sell |
264,809
-4,227
|
|
||||
|
2023
Q4 | $1.69M | Buy |
269,036
+56
|
|
||||
|
2023
Q3 | $1.92M | Buy |
268,980
+9,803
|
|
||||
|
2023
Q2 | $2.64M | Buy |
259,177
+195,525
|
|
||||
|
2023
Q1 | $577K | Buy |
63,652
+14,333
|
|
||||
|
2022
Q4 | $354K | Sell |
49,319
-264
|
|
||||
|
2022
Q3 | $323K | Buy |
49,583
+1,477
|
|
||||
|
2022
Q2 | $232K | Sell |
48,106
-802
|
|
||||
|
2022
Q1 | $278K | Sell |
48,908
-802
|
|
||||
|
2021
Q4 | $249K | Sell |
49,710
-400
|
|
||||
|
2021
Q3 | $333K | Buy |
50,110
+225
|
|
||||
|
2021
Q2 | $305K | Sell |
49,885
-64,988
|
|
||||
|
2021
Q1 | $764K | Sell |
114,873
-24,484
|
|
||||
|
2020
Q4 | $737K | Sell |
139,357
-6,498
|
|
||||
|
2020
Q3 | $1.09M | Buy |
145,855
+37,177
|
|
||||
|
2020
Q2 | $799K | Buy |
+108,678
|
|
||||
|
2019
Q4 | – | Sell |
-10,426
|
|
||||
|
2019
Q3 | $62K | Sell |
10,426
-56,144
|
|
||||
|
2019
Q2 | $213K | Sell |
66,570
-2,093
|
|
||||
|
2019
Q1 | $206K | Sell |
68,663
-251
|
|
||||
|
2018
Q4 | $259K | Buy |
68,914
+82
|
|
||||
|
2018
Q3 | $404K | Buy |
68,832
+900
|
|
||||
|
2018
Q2 | $384K | Buy |
67,932
+19,947
|
|
||||
|
2018
Q1 | $595K | Buy |
+47,985
|
|